American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

Published on February 2, 2024 by

Nabil Saba – Atlanta GA

← Go back

Nabil Saba

Winship Cancer Institute, Emory University

  • 25
  • 19

1365 Clifton Road
Building C
Atlanta, GA 30322
United States
Map It

404 778 1900

emory.edu

Dr. Saba is a Professor in the Department of Hematology and Medical Oncology and is an adjunct Professor of Otolaryngology. He serves as the Director of the Head and Neck Cancer Oncology Program at the Winship Cancer Institute. His research is focused on basic, clinical and translational research in head and neck malignancies and has focused on advancing the field in these diseases and improving patient outcome through the identification and clinical development of novel therapeutic approaches and correlative biomarkers. Dr Saba is a well-recognized international leader in the field of head and neck cancer clinical research especially in the area of EGFR targeting and immunotherapeutic applications. He has served as the principal investigator of more than 50 interventional and translational clinical trials and is currently serving as PI on two investigator initiated multi-institutional trials in head and neck cancer; Dr Saba is currently the chair of two cooperative group clinical trials in the field of head and neck oncology under the ECOG-ACRIN group; EA3163 is focusing on intensification of therapy for organ preservation in Sino nasal cancers; and EA3161 is investigating a maintenance anti-PD-1 strategy for the intermediate risk oropharyngeal squamous cell carcinomas. He has also received competitive NIH funding through an R21 grant investigating novel genomic approaches in HPV related and unrelated OPCA; Dr Saba is also the recipient of intramural funding and has been the co-Leader of project 4 of the previously funded Emory HNCA SPORE program; He has also received prior funds through the DOD mechanism; As a result of his recognized leadership role in HNCA research Dr Saba has been named the chair of the recurrent metastatic as well as rare tumor Task Forces of the Head and Neck Cancer NCI steering committee; Dr Saba also has more than 150 peer reviewed manuscripts and textbook chapter publications, and is the editor of a textbook updating the management of esophageal cancer;

Related

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc